-+ 0.00%
-+ 0.00%
-+ 0.00%

Apimeds to Issue 350,000 Unregistered Shares to FreeT for Apitox Rights

PUBT·11/20/2026 21:46:07
Listen to the news
Apimeds to Issue 350,000 Unregistered Shares to FreeT for Apitox Rights
  • Apimeds Pharmaceuticals US will issue 350,000 shares of common stock to FreeT by Dec. 1, 2026, as initial payment for Apitox-related rights.
  • The issuance is exempt from Securities Act registration under Section 4(a)(2).
  • Under a Nov. 12, 2026, amendment, the parties must jointly appoint an independent valuer within 60 days to value the rights.
  • Any valuation exceeding the initial payment requires additional consideration within 30 days of completion, payable in cash, common stock or both.
  • The company retains discretion over the form of any additional payment.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Apimeds Pharmaceuticals US Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-122743), on November 20, 2026, and is solely responsible for the information contained therein.